Target intelligence / Profile preview

Glutathione S-transferase mu 3 pseudogene 1 (GSTM3P1)

Target
GSTM3P1
Molecular classification
Other (long non-coding RNA, pseudogene-derived RNA)
01

Overview

Glutathione S-transferase mu 3 pseudogene 1 (GSTM3P1) is a human pseudogene that does not encode a functional protein, but rather produces a long non-coding RNA (lncRNA). This lncRNA has a regulatory function rather than a catalytic or receptor activity. GSTM3P1 is upregulated in kidney proximal tubular cells following hypoxic or ischemic injury. It mediates acute kidney injury (AKI) in part by interacting with and promoting degradation of the microRNA mir-668, which under normal conditions has a protective effect on the kidney. Mechanistically, GSTM3P1 lncRNA binds to mir-668, triggering sequence-directed microRNA degradation, thus relieving suppression of pro-apoptotic pathways and increasing tubular cell death in the context of ischemia. In mouse models, knockout or knockdown of the homologous pseudogene Gstm2-ps1 reduces kidney injury, suggesting that targeting this lncRNA may have therapeutic potential for AKI[1][4]. GSTM3P1 is not a conventional therapeutic target such as an enzyme, receptor, or transporter. While upregulation of GSTM3P1 has been associated with kidney injury biomarkers like NGAL, GSTM3P1 itself is not a clinically used biomarker.

Other names
dJ984P4.2GSTM3Pglutathione S-transferase M3 pseudogeneglutathione S-transferase mu 3 (brain) pseudogeneGSTM3P1
02

Biological functions

Regulation of apoptosisEpigenetic regulation via microRNA interaction
03

Disease associations

Acute kidney injury (AKI)

Beyond the preview

Go deeper on Glutathione S-transferase mu 3 pseudogene 1 (GSTM3P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutathione S-transferase mu 3 pseudogene 1 (GSTM3P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call